Why the study?
Does ambulatory blood pressure monitoring provide added prognostic value over conventional blood pressure measurements in patients receiving haemodialysis?
Does ambulatory blood pressure monitoring provide added prognostic value over conventional blood pressure measurements in patients receiving haemodialysis?
Answers are grounded in this paper and cite their sources.
ABPM currently lacks added value over conventional BP measurements in hemodialysis patients, highlighting the need for large-scale trials to establish specific BP targets rather than focusing on measurement techniques.
Ambulatory blood pressure monitoring (ABPM) has become popular in the investigation and management of patients with essential hypertension. In patients receiving haemodialysis, ABPM identifies patients who may fare worse in the long term. However, the available studies are small, and when conventional risk factors are included, there is no added value to ABPM over conventional BP measurements. In haemodialysis, ABPM remains an experimental investigation, and in the absence of specific, evidence-based targets for blood pressure in this population, it would be better to invest in large-scale trials to provide specific blood pressure targets and strategies, rather than concentrating on an alternative technique for blood pressure measurement.
No takes yet. Share an insight, caveat, or question.
Alan G. Jardine (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: